Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next?
FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
Evis Sala Announces a Landmark Oncology Partnership Between Albania and Italy
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
First Chemotherapy Session: What to Expect
Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma
SABCS 2026 Male Breast Cancer Advocate Scholarship
RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer
The ESO Ambassador Educational Event on Multidisciplinary Approach to Neoadjuvant and Post-Neoadjuvant Treatment in Breast Cancer takes place 30–31 October 2026 at the University Clinic of Radiotherapy and Oncology in Skopje, North Macedonia. Part of a series launched in celebration of the European School of Oncology's upcoming 50th Anniversary, the event is hosted by ESO […]
